Fear of new restrictions: stock rally is losing momentum

The US election result and the news about Biontech's corona vaccine have made investors cheer in the past few days. In the new week, however, the joy about it is likely to be suppressed by the fear of new restrictions. A new record high is unlikely.

The further increase in the number of corona infections is fueling fear of additional economic and social restrictions on the stock market. In the new week you are likely to suppress the joy of the supposed breakthrough with a vaccine a little more. Experts see the high effectiveness of a vaccine developed by Biontech and Pfizer against the lung disease Covid-19 and the victory of the Democrat Joe Biden in the US presidential election as a so-called "game changer", i.e. groundbreaking events. They caused a stock market rally and, from the end of October through November, drove the Dax by more than 1,800 points up to almost 13,300 points within a few days; a continuation seems uncertain, at least for the time being.

Biontech 92.32

According to analysts, a record high is unlikely for the leading German index in the new week. The current record is 13,795 points and dates from mid-February, i.e. shortly before the start of the Corona stock market crash. The stock exchanges received little impetus from the balance sheet season in the next few days. It is gradually drawing to a close. All corporations have now submitted quarterly figures from the Dax, so that only a few representatives from the MDax and SDax are on the agenda.

Dax
Dax 13,076.72

On Monday this is the real estate company Grand City Properties, on Tuesday the internet retailer for pet supplies Zooplus and on Wednesday the truck supplier SAF-Holland. The numbers of the troubled traditional company Thyssenkrupp are on the agenda on Thursday. The ticket marketer and event organizer CTS Eventim, which was heavily burdened by the corona pandemic, also reports. The series is completed by the solar and wind farm operator Encavis and the drug manufacturer Dermapharm (both on Monday) and the brake specialist Knorr-Bremse (on Thursday).

Key economic data for the new week will come from the US on Tuesday with retail sales and industrial production. "There are two faces of the US economy in the corona recovery: While retail sales exceeded the pre-crisis level in June, industrial production is clearly lagging behind," the economists at DekaBank analyze. "Nothing significant about this basic picture should change with the October figures either."

. (tagsToTranslate) Economy (t) Dax (t) Deutsche Börse (t) Biontech (t) Equity trading